2.08
price down icon3.70%   -0.08
after-market 시간 외 거래: 2.18 0.10 +4.81%
loading

Erasca Inc 주식(ERAS)의 최신 뉴스

Erasca Inc (ERAS) stock analysis: A comprehensive overview – US Post News - US Post News

pulisher
US Post News

Erasca shareholders elect directors, approve KPMG as auditor By Investing.com - Investing.com

pulisher
Investing.com

Erasca shareholders elect directors, approve KPMG as auditor - Investing.com India

pulisher
Investing.com India

HUB Cyber Security secures deals with government entities By Investing.com - Investing.com

pulisher
Investing.com

Quarterly Metrics: Quick and Current Ratios for Erasca Inc (ERAS) – DWinneX - The Dwinnex

pulisher
The Dwinnex

Bank of Baroda target raised by Investec as asset quality improves across segments By Investing.com - Investing.com UK

pulisher
Investing.com UK

Mastercard Foundation sells $52 million in Mastercard shares By Investing.com - Investing.com UK

pulisher
Investing.com UK

Biopharma Layoff Tracker 2024: Ginkgo, Cara, Barinthus and More Cut Staff - BioSpace

pulisher
BioSpace

Biopharma Layoff Tracker 2024: Ginkgo, Cara, Barinthus and More Cut Staff - BioSpace

pulisher
BioSpace

Biopharma Layoff Tracker 2024: Ginkgo, Cara, Barinthus and More Cut Staff - BioSpace

pulisher
BioSpace

Biopharma Layoff Tracker 2024: Ginkgo, Cara, Barinthus and More Cut Staff - BioSpace

pulisher
BioSpace

Biopharma Layoff Tracker 2024: Ginkgo, Cara, Barinthus and More Cut Staff - BioSpace

pulisher
BioSpace

Director Casdin Alexander W. acquired 80000 shares of Erasca Inc [ERAS] – Knox Daily - Knox Daily

pulisher
Knox Daily

Erasca Inc (ERAS) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - SETE News

pulisher
SETE News

Biopharma Layoff Tracker 2024: Cara, Barinthus, Agilent and More Cut Staff - BioSpace

pulisher
BioSpace

Erasca kicks off Phase III trial for naporafenib combo therapy in melanoma - Clinical Trials Arena

pulisher
Clinical Trials Arena

The Psychology of Erasca Inc Inc. (ERAS) Price Performance: Understanding Market Sentiment - The InvestChronicle

pulisher
The InvestChronicle

Investing in Erasca Inc (ERAS): What You Must Know – Knox Daily - Knox Daily

pulisher
Knox Daily

Erasca, Inc. (NASDAQ:ERAS) Short Interest Update - Defense World

pulisher
Defense World

Results from Erasca Inc (ERAS) show risk – US Post News - US Post News

pulisher
US Post News

Erasca, Inc. (NASDAQ:ERAS) Short Interest Update - Defense World

pulisher
Defense World

105711 Shares in Erasca, Inc. (NASDAQ:ERAS) Acquired by Sierra Summit Advisors LLC - Defense World

pulisher
Defense World

Erasca, Inc. (NASDAQ:ERAS) Short Interest Update - MarketBeat

pulisher
MarketBeat

A closer look at Erasca Inc (ERAS) is warranted – US Post News - US Post News

pulisher
US Post News

Taking a look at what insiders are doing to gauge the Erasca Inc (ERAS)'s direction – Knox Daily - Knox Daily

pulisher
Knox Daily

Biopharma Layoff Tracker 2024: Barinthus, Agilent, BMS and More Cut Staff - BioSpace

pulisher
BioSpace

Wall Street analysts’ outlook for Erasca Inc (ERAS) - SETE News

pulisher
SETE News

Head to Head Analysis: Erasca (NASDAQ:ERAS) and Ascendis Pharma A/S (NASDAQ:ASND) - Defense World

pulisher
Defense World

Head to Head Analysis: Erasca (NASDAQ:ERAS) and Ascendis Pharma A/S (NASDAQ:ASND) - Defense World

pulisher
Defense World

Erasca Inc (ERAS) rating initates by CapitalOne - Knox Daily

pulisher
Knox Daily

Erasca Insiders Placed Bullish Bets Worth US$3.97m - Simply Wall St

pulisher
Simply Wall St

Erasca Insiders Placed Bullish Bets Worth US$3.97m - Simply Wall St

pulisher
Simply Wall St

Merck (MRK) Keytruda Advanced Cervical Cancer Study Meets Goal - Yahoo Lifestyle Australia

pulisher
Yahoo Lifestyle Australia

Does Erasca Inc (ERAS) offer a good opportunity for investors? – Sete News - SETE News

pulisher
SETE News

ERAS Shares Experience Surge in Value – Knox Daily - Knox Daily

pulisher
Knox Daily

Was there any good news for Erasca Inc (ERAS) stock in the last session? – US Post News - US Post News

pulisher
US Post News

Should You Buy Erasca, Inc. (ERAS) After Golden Cross? - Zacks Investment Research

pulisher
Zacks Investment Research

Erasca Inc: How Does ERAS Perform? – Stocks Register - Stocks Register

pulisher
Stocks Register

Should You Buy Erasca, Inc. (ERAS) After Golden Cross? - Yahoo Canada Finance

pulisher
Yahoo Canada Finance

Why McKesson (MCK) is a Top Momentum Stock for the Long-Term - Zacks Investment Research

pulisher
Zacks Investment Research

Should You Buy Erasca, Inc. (ERAS) After Golden Cross? - Yahoo Finance

pulisher
Yahoo Finance

Swiss National Bank Sells 33500 Shares of Erasca, Inc. (NASDAQ:ERAS) - Defense World

pulisher
Defense World

Erasca Inc (ERAS)'s Ratio Roundup: Key Metrics for Trailing Twelve Months – DWinneX - The Dwinnex

pulisher
The Dwinnex

Recent Insider Activity Could Benefit Erasca Inc (ERAS) – Knox Daily - Knox Daily

pulisher
Knox Daily

Erasca Inc (ERAS)'s Ratio Roundup: Key Metrics for Trailing Twelve Months – DWinneX - The Dwinnex

pulisher
The Dwinnex

Is a Surprise Coming for Erasca (ERAS) This Earnings Season? - Yahoo Movies UK

pulisher
Yahoo Movies UK

Jonathan Lim Spends US$275k On Erasca Stock \ - Yahoo Canada Shine On

pulisher
Yahoo Canada Shine On

Stephen Taub: SEC Filings | 5/30/24 | II Research - II Research

pulisher
II Research

Observations on the Erasca Inc (NASDAQ:ERAS) Growth Curve – US Post News - US Post News

pulisher
US Post News

Erasca Inc: Navigating Market Fluctuations with a 661.59M Market Cap - The InvestChronicle

pulisher
The InvestChronicle
$150.99
price down icon 5.13%
$84.97
price down icon 0.20%
$25.78
price down icon 0.15%
$84.38
price down icon 2.57%
$451.55
price up icon 2.49%
$240.15
price up icon 7.74%
자본화:     |  볼륨(24시간):